Joseph M. Herman

Northwell Health — United States

Medicine · Health Sciences

86h-index31.4kcitations915works4.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pancreatic and Hepatic Oncology Research(456), Cancer Genomics and Diagnostics(198), Advanced Radiotherapy Techniques(120), Neuroendocrine Tumor Research Advances(103), Hepatocellular Carcinoma Treatment and Prognosis(88)

Publications908 total

De Novo high-volume metastatic prostate cancer with primary resistance to standard systemic therapy and exceptional response to PSMA-Lu177: A case report
International Cancer Conference Journal·2025Open Access
Applying Venn-Abers Predictors to Calibrate White Matter Hyperintensity Segmentations from Brain Images
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition·2025
Adjuvant Radiation for Resected Pancreatic Cancer: Historical Review and Current State
Seminars in Radiation Oncology·2025· 1 citedOpen Access
The Importance of Lymphopenia Severity in Anal Cancer Patients Undergoing Definitive Therapy
International Journal of Radiation Oncology*Biology*Physics·2025
Construction of a Low-Cost Perfusion Cadaver for Ultrasound Guided Vascular Access Training
Air Medical Journal·2025
Eradicating Cancer Stem Cells Using High Linear Energy Transfer Radiation Therapy Part 2: LET Painting and Other Advanced Techniques
Applied Radiation Oncology·2025
Eradicating Cancer Stem Cells Using High Linear Energy Transfer Radiation Therapy Part 1: Physics and Radiobiology
Applied Radiation Oncology·2025· 1 cited
Enhancing team efficiency for genetic risk assessment: Medical oncology-led germline testing for pancreatic cancer.
Journal of Clinical Oncology·2025· 1 cited
Clinical and dosimetric considerations for yttrium-90 glass microspheres radioembolization of intrahepatic cholangiocarcinoma, metastatic colorectal carcinoma, and metastatic neuroendocrine carcinoma: recommendations from an international multidisciplinary working group
European Journal of Nuclear Medicine and Molecular Imaging·2025· 3 citedOpen Access
Risk Reduction of Intrahepatic Abscess After Locoregional Therapy for Liver Cancer in Patients with Prior Hepatobiliary Intervention
Diagnostics·2025Open Access
A mixed methods evaluation of the Canopy Cancer Collective’s implementation of network-wide screening initiative in 2023.
Journal of Clinical Oncology·2025
The Black College Athletes’ Burden: A Critical Analysis of Race, Civic Engagement, and Activism of National Collegiate Athletic Association Athletes
Sociology of Sport Journal·2024· 1 cited
Comparison of neoadjuvant chemotherapy plus radiation vs. chemotherapy alone on complete pathologic response in pancreatic adenocarcinoma: an analysis of the national cancer database
Discover Medicine·2024Open Access
Phase 1 Study of Adjuvant Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor–Transduced Pancreatic Tumor Cell Vaccine, Low-Dose Cyclophosphamide, and Stereotactic Body Radiation Therapy Followed by FOLFIRINOX in High-Risk Resected Pancreatic Ductal Adenocarcinoma
International Journal of Radiation Oncology*Biology*Physics·2024· 7 cited
NRG Oncology International Consensus Contouring Atlas on Target Volumes and Dosing Strategies for Dose-Escalated Pancreatic Cancer Radiation Therapy
International Journal of Radiation Oncology*Biology*Physics·2024· 21 citedOpen Access
Organ at Risk Dose Constraints in Conventionally Fractionated Pelvic Radiation Therapy: A Systematic Review of Clinical Trials
International Journal of Radiation Oncology*Biology*Physics·2024· 1 citedOpen Access
Neoadjuvant Radiation Practice Patterns in Resected Pancreatic Ductal Adenocarcinoma at Academic Cancer Centers Participating in the Canopy Cancer Collective Learning Health Network
International Journal of Radiation Oncology*Biology*Physics·2024Open Access
Postoperative Adverse Events Following Neoadjuvant Therapy and Surgery for Borderline Resectable Pancreatic Cancer in a Phase 2 Clinical Trial (Alliance A021501)
Annals of Surgical Oncology·2024· 4 citedOpen Access
Variation in outcomes and practice patterns among patients with localized pancreatic cancer: the impact of the pancreatic cancer multidisciplinary clinic
Frontiers in Oncology·2024· 4 citedOpen Access
Treatment Terminations During Radiation Therapy: A 10-Year Experience
Practical Radiation Oncology·2024· 1 cited
page 1 of 46Next →

Frequent Co-authors

Christopher L. Wolfgang(22), Daniel A. Laheru(18), John L. Cameron(16), Timothy M. Pawlik(14), Ralph H. Hruban(13), Richard D. Schulick(12), Alison P. Klein(8), Michael A. Choti(8), Michael Goggins(6), Christine A. Iacobuzio–Donahue(6), Albert C. Koong(6), Brian M. Wolpin(6), Barish H. Edil(6), Matthew H. G. Katz(6), Timothy M. Pawlik(6), Robert A. Wolff(5), Aaron T. Wild(5), Lei Zheng(5), Matthew J. Weiss(5), Andrew H. Ko(4)